NCT03805737

Indoor Daylight Photo Dynamic Therapy for Actinic Keratosis

Indoor Daylight Photo Dynamic Therapy (PDT) for Actinic Keratosis

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 43 (actual)
• Sponsor: Dartmouth-Hitchcock Medical Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to understand better if indoor daylight Photo Dynamic Therapy (PDT) can provide effective lesion clearing versus conventional red lamp light therapy.

Detailed description

Subjects who enroll into this research study, their participation in this study will last up to 6 months. They will be asked to return to the clinic 3-4 times. Subjects will be randomized into one of two study arms: Arm 1 - Indoor Daylight PDT Therapy Arm 2 - FDA Approved Standard Light Therapy Treatment

Conditions

• Actinic Keratosis

Interventions

Type	Name	Description
OTHER	Amulez and sunlight	Amulez and sun exposure for 2 hours
OTHER	Amulez and red light treatment	Amulez and red light treatment for 10 minutes

Timeline

• Start date: 2019-11-01
• Primary completion: 2021-10-06
• Completion: 2021-10-06
• First posted: 2019-01-16
• Last updated: 2022-01-20

Locations

1 site across 1 country: United States